• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4642354)   Today's Articles (6972)   Subscriber (50472)
For: Holleran JL, Fourcade J, Egorin MJ, Eiseman JL, Parise RA, Musser SM, White KD, Covey JM, Forrest GL, Pan SS. IN VITRO METABOLISM OF THE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR, WORTMANNIN, BY CARBONYL REDUCTASE. Drug Metab Dispos 2004;32:490-6. [PMID: 15100170 DOI: 10.1124/dmd.32.5.490] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
Number Cited by Other Article(s)
1
Xue D, He H, Gao S. Strategies for the Total Synthesis of the Furanosteroids: wortmannin and viridin. CHEM LETT 2021. [DOI: 10.1246/cl.200841] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
2
Senapati BK. Recent progress in the synthesis of the furanosteroid family of natural products. Org Chem Front 2021. [DOI: 10.1039/d0qo01454k] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
3
Inhibition of Phosphatidylinositol 3-kinease suppresses formation and progression of experimental abdominal aortic aneurysms. Sci Rep 2017;7:15208. [PMID: 29123158 PMCID: PMC5680315 DOI: 10.1038/s41598-017-15207-w] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Accepted: 10/23/2017] [Indexed: 01/10/2023]  Open
4
Matsuda D, Ohshiro T, Ohtawa M, Yamazaki H, Nagamitsu T, Tomoda H. In vitro metabolism of pyripyropene A and ACAT inhibitory activity of its metabolites. J Antibiot (Tokyo) 2015;68:27-34. [PMID: 25005817 DOI: 10.1038/ja.2014.91] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2014] [Revised: 05/12/2014] [Accepted: 06/10/2014] [Indexed: 11/09/2022]
5
Wu P, Hu Y. Small molecules targeting phosphoinositide 3-kinases. MEDCHEMCOMM 2012. [DOI: 10.1039/c2md20044a] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
6
Memon AA, Munk M, Nexo E, Sorensen BS. Calcium-induced apoptosis is delayed by HER1 receptor signalling through the Akt and PLCγ pathways in bladder cancer cells. Scandinavian Journal of Clinical and Laboratory Investigation 2010;71:45-51. [PMID: 21087080 DOI: 10.3109/00365513.2010.536250] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
7
Salvatorelli E, Menna P, Lusini M, Covino E, Minotti G. Doxorubicinolone Formation and Efflux: A Salvage Pathway against Epirubicin Accumulation in Human Heart. J Pharmacol Exp Ther 2009;329:175-84. [DOI: 10.1124/jpet.108.149260] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
8
Zhao R, Kalvass JC, Yanni SB, Bridges AS, Pollack GM. Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration. Drug Metab Dispos 2008;37:529-35. [PMID: 19114463 DOI: 10.1124/dmd.107.019893] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
9
Marone R, Cmiljanovic V, Giese B, Wymann MP. Targeting phosphoinositide 3-kinase: moving towards therapy. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2007;1784:159-85. [PMID: 17997386 DOI: 10.1016/j.bbapap.2007.10.003] [Citation(s) in RCA: 451] [Impact Index Per Article: 26.5] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Received: 08/15/2007] [Revised: 09/28/2007] [Accepted: 10/05/2007] [Indexed: 01/08/2023]
10
Salvatorelli E, Menna P, Gianni L, Minotti G. Defective Taxane Stimulation of Epirubicinol Formation in the Human Heart: Insight into the Cardiac Tolerability of Epirubicin-Taxane Chemotherapies. J Pharmacol Exp Ther 2006;320:790-800. [PMID: 17135345 DOI: 10.1124/jpet.106.116160] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]  Open
11
Matsunaga T, Shintani S, Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab Pharmacokinet 2006;21:1-18. [PMID: 16547389 DOI: 10.2133/dmpk.21.1] [Citation(s) in RCA: 119] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
12
Wipf P, Halter RJ. Chemistry and biology of wortmannin. Org Biomol Chem 2005;3:2053-61. [PMID: 15917886 DOI: 10.1039/b504418a] [Citation(s) in RCA: 138] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
13
Rosemond MJC. Measurement of xenobiotic carbonyl reduction in human liver fractions. CURRENT PROTOCOLS IN TOXICOLOGY 2005;Chapter 4:Unit4.17. [PMID: 23045124 DOI: 10.1002/0471140856.tx0417s25] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA